CLINICAL STUDIES
Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST)
Spencer B. King, III, MD, MACC*,
Andrzej S. Kosinski, PhD ,
Robert A. Guyton, MD, FACC ,
Nicholas J. Lembo, MD, FACC*,
William S. Weintraub, MD, FACC* for the Emory Angioplasty Versus Surgery Trial (EAST) Investigators
* Emory University School of Medicine, Department of Medicine, Division of Cardiology, Atlanta, Georgia, USA
Emory University School of Medicine, Department of Surgery, Division of Cardiothoracic Surgery, Atlanta, Georgia, USA
Emory University School of Medicine, Department of Biostatistics, Emory University School of Public Health, Atlanta, Georgia, USA
Manuscript received April 22, 1999;
revised manuscript received September 20, 1999,
accepted December 17, 1999.
Reprint requests and correspondence: Dr. Spencer B. King, III, Emory University Hospital, Suite F606, 1364 Clifton Road Northeast, Atlanta, Georgia 30322
OBJECTIVES
To evaluate the long-term outcome of patients randomized to coronary bypass surgery or coronary angioplasty.
BACKGROUND
The Emory Angioplasty versus Surgery Trial (EAST) is a single center randomized comparison of a strategy of initial coronary angioplasty (n = 198) or coronary bypass surgery (n = 194) for patients with multivessel coronary artery disease. The primary end point (death, myocardial infarction or a large ischemic defect at 3 years) was not different, and repeat revascularization was significantly greater in the angioplasty group. Subsequently, the National Heart, Lung and Blood Institute supported a five-year extension of the trial.
METHODS
After the three year anniversary visit, annual questionnaires, telephone contact and examination of medical records were accomplished until death or the eight year anniversary in 100% of the patients surviving at 3 years.
RESULTS
Survival at 8 years is 79.3% in the angioplasty group and 82.7% in the surgical group (p = 0.40). Patients with proximal left anterior descending stenosis and those with diabetes tended to have better late survival with surgical intervention although not reaching statistical significance. After the first 3 years, repeat interventions remained relatively equal for both treatment groups.
CONCLUSIONS
Long-term survival is not significantly different between angioplasty and surgery, and late (three to eight year) revascularization procedures were infrequent. Patients without treated diabetes had similar survival in both groups.
|
Abbreviations and Acronyms
| | BARI | = Bypass Angioplasty Revascularization Investigation | | CAD | = coronary artery disease | | EAST | = Emory Angioplasty versus Surgery Trial | | MI | = myocardial infarction | | NHLBI | = National Heart, Lung and Blood Institute | | PTCA | = percutaneous transluminal coronary angioplasty |
|
This article has been cited by other articles:
|
|
|
|
 
G. Weisz, M. B. Leon, D. R. Holmes Jr, D. J. Kereiakes, J. J. Popma, P. S. Teirstein, S. A. Cohen, H. Wang, D. E. Cutlip, and J. W. Moses
Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial.
J. Am. Coll. Cardiol.,
April 28, 2009;
53(17):
1488 - 1497.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Daemen, K. H. Kuck, C. Macaya, V. LeGrand, M. Vrolix, D. Carrie, I. Sheiban, M. J. Suttorp, P. Vranckx, T. Rademaker, et al.
Multivessel Coronary Revascularization in Patients With and Without Diabetes Mellitus: 3-Year Follow-Up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) Trial
J. Am. Coll. Cardiol.,
December 9, 2008;
52(24):
1957 - 1967.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Daemen, E. Boersma, M. Flather, J. Booth, R. Stables, A. Rodriguez, G. Rodriguez-Granillo, W. A. Hueb, P. A. Lemos, and P. W. Serruys
Long-Term Safety and Efficacy of Percutaneous Coronary Intervention With Stenting and Coronary Artery Bypass Surgery for Multivessel Coronary Artery Disease: A Meta-Analysis With 5-Year Patient-Level Data From the ARTS, ERACI-II, MASS-II, and SoS Trials
Circulation,
September 9, 2008;
118(11):
1146 - 1154.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. M. Bravata, A. L. Gienger, K. M. McDonald, V. Sundaram, M. V. Perez, R. Varghese, J. R. Kapoor, R. Ardehali, D. K. Owens, and M. A. Hlatky
Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery
Ann Intern Med,
November 20, 2007;
147(10):
703 - 716.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Gibbons and S. D. Fihn
Coronary Revascularization: New Evidence, New Challenges
Ann Intern Med,
November 20, 2007;
147(10):
732 - 734.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. Anderson, C. D. Adams, E. M. Antman, C. R. Bridges, R. M. Califf, D. E. Casey Jr, W. E. Chavey II, F. M. Fesmire, J. S. Hochman, T. N. Levin, et al.
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine
J. Am. Coll. Cardiol.,
August 14, 2007;
50(7):
e1 - e157.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. Anderson, C. D. Adams, E. M. Antman, C. R. Bridges, R. M. Califf, D. E. Casey Jr, W. E. Chavey II, F. M. Fesmire, J. S. Hochman, T. N. Levin, et al.
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine
J. Am. Coll. Cardiol.,
August 14, 2007;
50(7):
652 - 726.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. R. Holmes Jr, L. J. Kim, M. M. Brooks, K. E. Kip, H. V. Schaff, K. M. Detre, R. L. Frye, and Bypass Angioplasty Revascularization Investigation
The effect of coronary artery bypass grafting on specific causes of long-term mortality in the Bypass Angioplasty Revascularization Investigation
J. Thorac. Cardiovasc. Surg.,
July 1, 2007;
134(1):
38 - 46.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Rao, O. Aziz, S. S. Panesar, C. Jones, S. Morris, A. Darzi, and T. Athanasiou
Cost effectiveness analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery
BMJ,
March 24, 2007;
334(7594):
621 - 621.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Berry, J.-C. Tardif, and M. G. Bourassa
Coronary Heart Disease in Patients With Diabetes: Part II: Recent Advances in Coronary Revascularization
J. Am. Coll. Cardiol.,
February 13, 2007;
49(6):
643 - 656.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Ben-Gal, Y. Moshkovitz, N. Nesher, G. Uretzky, R. Braunstein, A. Hendler, E. Zivi, I. Herz, and R. Mohr
Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Patients with Diabetes Mellitus
Ann. Thorac. Surg.,
November 1, 2006;
82(5):
1692 - 1697.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. B. Barner
Status of percutaneous coronary intervention and coronary artery bypass.
Eur. J. Cardiothorac. Surg.,
September 1, 2006;
30(3):
419 - 424.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. A. Guyton
Coronary Artery Bypass is Superior to Drug-Eluting Stents in Multivessel Coronary Artery Disease
Ann. Thorac. Surg.,
June 1, 2006;
81(6):
1949 - 1957.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Kaehler, R. Koester, W. Billmann, C. Schroeder, H.-J. Rupprecht, T. Ischinger, R. Jahns, A. Vogt, M. Lampen, R. Hoffmann, et al.
13-year follow-up of the German angioplasty bypass surgery investigation
Eur. Heart J.,
October 2, 2005;
26(20):
2148 - 2153.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. B. King III, G. Dangas, J. W. Moses, S. B. King III, G. Dangas, and J. W. Moses
Surgery Is Preferred for the Diabetic With Multivessel Disease
Circulation,
September 6, 2005;
112(10):
1500 - 1515.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Calafiore, M. Di Mauro, G. Di Giammarco, G. Teodori, A. L. Iaco, V. Mazzei, G. Vitolla, and M. Contini
Single Versus Bilateral Internal Mammary Artery for Isolated First Myocardial Revascularization in Multivessel Disease: Long-Term Clinical Results in Medically Treated Diabetic Patients
Ann. Thorac. Surg.,
September 1, 2005;
80(3):
888 - 895.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. J. Malenka, B. J. Leavitt, M. J. Hearne, J. F. Robb, Y. R. Baribeau, T. J. Ryan, R. E. Helm, M. A. Kellett, H. L. Dauerman, L. J. Dacey, et al.
Comparing Long-Term Survival of Patients With Multivessel Coronary Disease After CABG or PCI: Analysis of BARI-Like Patients in Northern New England
Circulation,
August 30, 2005;
112(9_suppl):
I-371 - I-376.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. L. Hannan, M. J. Racz, G. Walford, R. H. Jones, T. J. Ryan, E. Bennett, A. T. Culliford, O. W. Isom, J. P. Gold, and E. A. Rose
Long-Term Outcomes of Coronary-Artery Bypass Grafting versus Stent Implantation
N. Engl. J. Med.,
May 26, 2005;
352(21):
2174 - 2183.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. T. van Domburg, J. J.M. Takkenberg, L. J. Noordzij, F. Saia, L. A. van Herwerden, P. W.J.C. Serruys, and A. J.J.C. Bogers
Late Outcome After Stenting or Coronary Artery Bypass Surgery for the Treatment of Multivessel Disease: A Single-Center Matched-Propensity Controlled Cohort Study
Ann. Thorac. Surg.,
May 1, 2005;
79(5):
1563 - 1569.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. D. Flaherty and C. J. Davidson
Diabetes and Coronary Revascularization
JAMA,
March 23, 2005;
293(12):
1501 - 1508.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Hlatky, D. B. Boothroyd, K. A. Melsop, M. M. Brooks, D. B. Mark, B. Pitt, G. S. Reeder, W. J. Rogers, T. J. Ryan, P. L. Whitlow, et al.
Medical Costs and Quality of Life 10 to 12 Years After Randomization to Angioplasty or Bypass Surgery for Multivessel Coronary Artery Disease
Circulation,
October 5, 2004;
110(14):
1960 - 1966.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Pfisterer and for the TIME Investigators
Long-Term Outcome in Elderly Patients With Chronic Angina Managed Invasively Versus by Optimized Medical Therapy: Four-Year Follow-Up of the Randomized Trial of Invasive Versus Medical Therapy in Elderly Patients (TIME)
Circulation,
September 7, 2004;
110(10):
1213 - 1218.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Lichtenberg, U. Klima, H. Paeschke, M. Pichlmaier, S. Ringes-Lichtenberg, T. Walles, H. Goerler, and A. Haverich
Impact of multivessel coronary artery disease on outcome after isolated minimally invasive bypass grafting of the left anterior descending artery
Ann. Thorac. Surg.,
August 1, 2004;
78(2):
487 - 491.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Lichtenberg, U. Klima, H. Paeschke, M. Pichlmaier, S. Ringes-Lichtenberg, T. Walles, H. Goerler, and A. Haverich
Impact of diabetes on outcome following isolated minimally invasive bypass grafting of the left anterior descending artery
Ann. Thorac. Surg.,
July 1, 2004;
78(1):
129 - 134.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. E. Boden
Surgery, angioplasty, or medical therapy for symptomatic multivessel coronary artery disease: Is there an indisputable "winning strategy" from evidence-based clinical trials?
J. Am. Coll. Cardiol.,
May 19, 2004;
43(10):
1752 - 1754.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. W. Vetrovec
Don't blame the stents
J. Am. Coll. Cardiol.,
April 21, 2004;
43(8):
1355 - 1357.
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Lev-Ran, R. Mohr, D. Pevni, N. Nesher, Y. Weissman, D. Loberman, and G. Uretzky
Bilateral internal thoracic artery grafting in diabetic patients: Short-term and long-term results of a 515-patient series
J. Thorac. Cardiovasc. Surg.,
April 1, 2004;
127(4):
1145 - 1150.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. M.G. Legrand, P. W. Serruys, F. Unger, B. A. van Hout, M. C.M. Vrolix, G. M.P. Fransen, T. T. Nielsen, P. K. Paulsen, R. S. Gomes, J. M.G. de Queiroz e Melo, et al.
Three-Year Outcome After Coronary Stenting Versus Bypass Surgery for the Treatment of Multivessel Disease
Circulation,
March 9, 2004;
109(9):
1114 - 1120.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C Casey and D. P Faxon
Multi-vessel coronary disease and percutaneous coronary intervention
Heart,
March 1, 2004;
90(3):
341 - 346.
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. E.J. West, P. N. Ruygrok, C. M.C. Disco, M. W.I. Webster, W. K. Lindeboom, W. W. O'Neill, N. F. Mercado, and P. W. Serruys
Clinical and Angiographic Predictors of Restenosis After Stent Deployment in Diabetic Patients
Circulation,
February 24, 2004;
109(7):
867 - 873.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. R. Holmes Jr, B. G. Firth, and D. L. Wood
Paradigm shifts in cardiovascular medicine
J. Am. Coll. Cardiol.,
February 18, 2004;
43(4):
507 - 512.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Abizaid, M. A. Costa, D. Blanchard, M. Albertal, H. Eltchaninoff, G. Guagliumi, L. Geert-Jan, A. S. Abizaid, A. G.M.R. Sousa, E. Wuelfert, et al.
Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients: Insights from the RAVEL Trial
Eur. Heart J.,
January 2, 2004;
25(2):
107 - 112.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. T. Hurst and R. W. Lee
Increased Incidence of Coronary Atherosclerosis in Type 2 Diabetes Mellitus: Mechanisms and Management
Ann Intern Med,
November 18, 2003;
139(10):
824 - 834.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. A. Henderson, S. J. Pocock, T. C. Clayton, R. Knight, K. A. A. Fox, D. G. Julian, D. A. Chamberlain, and Second Randomized Intervention Treatment of Angina
Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy
J. Am. Coll. Cardiol.,
October 1, 2003;
42(7):
1161 - 1170.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Endo, Y. Tomizawa, and H. Nishida
Bilateral Versus Unilateral Internal Mammary Revascularization in Patients With Diabetes
Circulation,
September 16, 2003;
108(11):
1343 - 1349.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. K. Wolf, E. L. Alderman, M. P. Caskey, A. R. Raczkowski, M. K. Dullum, D. C. Lundell, A. C. Hill, N. Wang, and M. A. Daniel
Clinical and six-month angiographic evaluation of coronary arterial graft interrupted anastomoses by use of a self-closing clip device: a multicenter prospective clinical trial
J. Thorac. Cardiovasc. Surg.,
July 1, 2003;
126(1):
168 - 177.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K.-H. Mak and D. P. Faxon
Clinical studies on coronary revascularization in patients with type 2 diabetes
Eur. Heart J.,
June 2, 2003;
24(12):
1087 - 1103.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. N. Hoffman, J. A. TenBrook Jr, M. P. Wolf, S. G. Pauker, D. N. Salem, and J. B. Wong
A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes
J. Am. Coll. Cardiol.,
April 16, 2003;
41(8):
1293 - 1304.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. K. McGuire, K. J. Anstrom, and E. D. Peterson
Influence of the Bypass Angioplasty Revascularization Investigation National Heart, Lung, and Blood Institute Diabetic Clinical Alert on Practice Patterns: Results from the National Cardiovascular Network Database
Circulation,
April 15, 2003;
107(14):
1864 - 1870.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Lincoff
Important Triad in Cardiovascular Medicine: Diabetes, Coronary Intervention, and Platelet Glycoprotein IIb/IIIa Receptor Blockade
Circulation,
March 25, 2003;
107(11):
1556 - 1559.
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. L Williams, A. Vazir, and A. G Zaman
Review: The management of stable angina in diabetes
The British Journal of Diabetes & Vascular Disease,
January 1, 2003;
3(1):
18 - 25.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. H. Cole, E. L. Jones, J. M. Craver, R. A. Guyton, D. C. Morris, J. S. Douglas Jr, Z. Ghazzal, and W. S. Weintraub
Outcomes of repeat revascularization in diabetic patients with prior coronary surgery
J. Am. Coll. Cardiol.,
December 4, 2002;
40(11):
1968 - 1975.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. D. Michaels and K. Chatterjee
Angioplasty Versus Bypass Surgery for Coronary Artery Disease
Circulation,
December 3, 2002;
106
(23):
e187 - e190.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P F Ludman
Percutaneous coronary intervention in diabetics: time to consider "intimal remodelling therapy"?
Heart,
September 1, 2002;
88(3):
213 - 215.
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Ono, J. Kobayashi, Y. Sasako, K. o Bando, O. Tagusari, K. Niwaya, H. Imanaka, T. Nakatani, and S. Kitamura
The impact of diabetic retinopathy on long-term outcome following coronary artery bypass graft surgery
J. Am. Coll. Cardiol.,
August 7, 2002;
40(3):
428 - 436.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P.J. de Feyter, P.W. Serruys, F. Unger, R. Beyar, V. de Valk, S. Milo, R. Simon, D. Regensburger, P.A. Crean, E. McGovern, et al.
Bypass Surgery Versus Stenting for the Treatment of Multivessel Disease in Patients With Unstable Angina Compared With Stable Angina
Circulation,
May 21, 2002;
105(20):
2367 - 2372.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A Kapur and I S Malik
Is surgery still the preferred option for coronary revascularisation in diabetics with multivessel coronary disease?
Heart,
May 1, 2002;
87(5):
407 - 409.
[Full Text]
[PDF]
|
|
|
|
|
|
|
F.R. Eberli and B. Meier
Coronary bypass surgery vs coronary angioplasty: a look to the past for new insights into the future
Eur. Heart J.,
April 1, 2002;
23(7):
511 - 514.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R.T van Domburg, D.P Foley, A Breeman, L.A van Herwerden, and P.W Serruys
Coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty. Twenty-year clinical outcome
Eur. Heart J.,
April 1, 2002;
23(7):
543 - 549.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Abizaid, M. A. Costa, M. Centemero, A. S. Abizaid, V. M.G. Legrand, R. V. Limet, G. Schuler, F. W. Mohr, W. Lindeboom, A. G.M.R. Sousa, et al.
Clinical and Economic Impact of Diabetes Mellitus on Percutaneous and Surgical Treatment of Multivessel Coronary Disease Patients: Insights From the Arterial Revascularization Therapy Study (ARTS) Trial
Circulation,
July 31, 2001;
104(5):
533 - 538.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Seabra-Gomes
Every piece is important to build a puzzle. What can we learn from early experiences with balloon PTCA?
Eur. Heart J.,
June 1, 2001;
22(11):
891 - 893.
[PDF]
|
|
|
|
|
|
|
J P Pell, D Walsh, J Norrie, G Berg, A D Colquhoun, K Davidson, H Eteiba, A Faichney, A Flapan, K J Hogg, et al.
Outcomes following coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in the stent era: a prospective study of all 9890 consecutive patients operated on in Scotland over a two year period
Heart,
June 1, 2001;
85(6):
662 - 666.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
S. B. King III
Coronary artery bypass graft or percutaneous coronary interventions in patients with diabetes: another nail in the coffin or "too close to call?"
J. Am. Coll. Cardiol.,
March 15, 2001;
37(4):
1016 - 1018.
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. E. Sobel
Acceleration of Restenosis by Diabetes : Pathogenetic Implications
Circulation,
March 6, 2001;
103(9):
1185 - 1187.
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Braunwald, E. M. Antman, J. W. Beasley, R. M. Califf, M. D. Cheitlin, J. S. Hochman, R. H. Jones, D. Kereiakes, J. Kupersmith, T. N. Levin, et al.
ACC/AHA guidelines for the management of patients with unstable angina and non-st-segment elevation myocardial infarction: A report of the american college of cardiology/ american heart association task force on practice guidelines (committee on the management of patients with unstable angina)
J. Am. Coll. Cardiol.,
September 1, 2000;
36(3):
970 - 1062.
[Full Text]
[PDF]
|
|
|
|
|
|
|
In EAST, Equal Survival at 8 Years with PTCA and CABG
Journal Watch Cardiology,
June 16, 2000;
2000(616):
6 - 6.
[Full Text]
|
|
|
|
|
|
|
S. B. King III
Acute myocardial infarction: are diabetics different?
J. Am. Coll. Cardiol.,
May 1, 2000;
35(6):
1513 - 1515.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. C. Friesinger II and J. A. Gavin III
Diabetes and the cardiologists: a call to action
J. Am. Coll. Cardiol.,
April 1, 2000;
35(5):
1130 - 1133.
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. E. Kip, E. L. Alderman, M. G. Bourassa, M. M. Brooks, L. Schwartz, D. R. Holmes Jr, R. M. Califf, P. L. Whitlow, B. R. Chaitman, and K. M. Detre
Differential Influence of Diabetes Mellitus on Increased Jeopardized Myocardium After Initial Angioplasty or Bypass Surgery: Bypass Angioplasty Revascularization Investigation
Circulation,
April 23, 2002;
105(16):
1914 - 1920.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
